Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study

Overview of attention for article published in Orphanet Journal of Rare Diseases, October 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 2 news outlets

twitter: 2 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 31 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Nusinersen May Stabilize Disease Status in SMA Types 2 and 3

Neurology Advisor , 28 Nov 2022

_.

Disease-Modifying Therapies Halt Progression in Patients With SMA Types 2, 3

AJMC, 27 Nov 2022

The new report is based on real-world data from a patient registry and shows some patients even regain motor function under…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.